Finding Genes Linked to Cartilage Tumors and Blood Vessel Issues
Part of Bones, joints & muscles, Cancer, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This study uses genetic testing to find genes that cause certain types of cartilage tumors and blood vessel problems. If you or your child has one of these conditions, joining could help doctors understand what causes them and find better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child is 2 years old or older.
- You have been diagnosed with a condition that causes cartilage tumors (like enchondromas or osteochondromas) or blood vessel issues (vascular anomalies).
- You are willing to provide a blood or saliva sample for genetic testing.
- You are able to travel to the study center for appointments if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at bone (skeletal) disorders to better understand possible genetic causes, especially when phosphate levels or bone growth are affected. You may join either if you (or your child) has a bone disorder, or if you’re an unaffected family member who might help compare results.
This study is looking at different types of cartilage tumors to find better ways to diagnose and treat them. If you have a confirmed cartilage tumor, you may be able to join and help researchers learn more about your condition.
This study looks at genetic causes of skeletal (bone growth) disorders in people who show signs based on height and bone imaging. Genetic testing may help explain what’s behind the condition, especially when it seems inherited.
This study looks at genetic (DNA) factors that may contribute to certain blood disorders. You may be invited if you or a close family member is receiving care for a blood condition like MDS or MPN, and the study also includes related relatives.
This study tracks the health of people with a confirmed ACTA2 gene change over time to better understand the disease. It may help researchers learn how to improve care for this condition.
This trial looks for gene changes that may explain rare conditions, even when the diagnosis is not fully understood. It may help families who have a rare condition or who are related to someone with one.
Hear when a new Enchondromatosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.